'Antiviral agents' presentation slideshows

General Medical Emergencies: Part I

General Medical Emergencies: Part I. Major Topics Communicable / Infectious Diseases. HIV Infection and AIDS Diphtheria Encephalitis Hepatitis Herpes: Disseminated Measles Meningitis. Mononucleosis Mumps Pertussis Shingles (Herpes Zoster) Tuberculosis Varicella (Chickenpox).

2.04k views • 178 slides

Maternal-Child Health Nursing

1.19k views • 75 slides

829 views • 67 slides

Infections in Pregnancy

1.43k views • 46 slides

Entecavir 0440120 ? ? 0440229 ??? 0440218 ??? 0440217 ???

Gospel for HBV Patients. Entecavir 0440120 ? ? 0440229 ??? 0440218 ??? 0440217 ???. The battle against the HBV. Human hepatitis B virus ( HBV ), . remains a major agent of liver infection and a cause of liver disease throughout the world.

610 views • 40 slides

Treatment and Prophylaxis of Influenza Masoud Mardani M.D. Professor of Infectious Diseases

Treatment and Prophylaxis of Influenza Masoud Mardani M.D. Professor of Infectious Diseases. Seasonasl Influenza. Prophylaxis and Treatment. Antiviral Therapies for Influenza. Neuraminidase (NA). NA Inhibitors Oseltamivir Zanamivir. Matrix protein (M2 ). M2 Inhibitors Amantadine

595 views • 38 slides

David Fletcher, MD Department of Medicine University of Toronto

Complicated cases. David Fletcher, MD Department of Medicine University of Toronto. CASE 1 . 54 yr /o man HIV positive 8 yrs ago Tenofovir /FTC/RTV/ Atazanavir x 4 yrs Previously documented NNRTI resistance with Y181C, G190A,and mixed m184v/ wt CD4 320 HIV Viral Load<40. CASE 1 .

339 views • 21 slides

THE ROLE OF ANTIFUNGAL AND ANTIVIRAL AGENTS IN PRIMARY DENTAL CARE

THE ROLE OF ANTIFUNGAL AND ANTIVIRAL AGENTS IN PRIMARY DENTAL CARE. Matt Dickie. Introduction. Significantly limited spectrum of antifungal and antiviral drugs when compared to the range of antibiotics. Essentially there are three antifungal agents and 2 antiviral agents. Anti Fungals.

214 views • 21 slides

Working Group Four: Antivirals and Non-Specific Approaches, Treatments and Immunotherapies

John R. LaMontagne Memorial Symposium on Pandemic Influenza Research April 4-5, 2005 Institute of Medicine. Working Group Four: Antivirals and Non-Specific Approaches, Treatments and Immunotherapies Research Recommendations. Research Priorities: Short-term (1-2 Years).

189 views • 9 slides

Working Group Four: Antivirals and Non-Specific Approaches, Treatments and Immunotherapies

John R. LaMontagne Memorial Symposium on Pandemic Influenza Research April 4-5, 2005 Institute of Medicine. Working Group Four: Antivirals and Non-Specific Approaches, Treatments and Immunotherapies Research Recommendations. Research Priorities: Short-term (1-2 Years).

96 views • 9 slides